Search the Newsreel

67,700 Shares in PROCEPT BioRobotics Corporation $PRCT Bought by Quantinno Capital Management LP

Quantinno Capital Management LP recently acquired 67,700 shares of PROCEPT BioRobotics Corporation (NASDAQ:PRCT) worth approximately $1.69 million, making it a new stakeholder in the company. Institutional investors collectively own 89.46% of PROCEPT BioRobotics, which faces mixed analyst ratings, a consensus "Hold" with a $28 …

Why PROCEPT BioRobotics (PRCT) Could Be 10% Undervalued On Reaffirmed Guidance

PROCEPT BioRobotics (PRCT) is back in focus after reaffirming its full-year guidance following Q2 2026 results, leading to a recent stock price increase despite previous longer-term declines. While a popular narrative suggests the stock is 9.4% undervalued with a fair value of $25.26 per …

PROCEPT BioRobotics Corporation Notice of September 22, 2026 Application Deadline for Class Action Lawsuit - Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP Before Application Deadline

Hagens Berman Sobol Shapiro LLP has filed a securities class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) on behalf of investors who purchased shares between February 28, 2024, and February 25, 2026. The lawsuit alleges that PROCEPT misled investors regarding its handpiece sales …

PRCT DEADLINE: ROSEN, A LEADING LAW FIRM Encourages PROCEPT

The Rosen Law Firm is encouraging investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) who suffered losses exceeding $100K to secure counsel before the September 22, 2026, lead plaintiff deadline. The firm reminds purchasers of PRCT common stock between February 28, 2024, and February 25, …

Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Seeking Recovery to Contact the Firm Before September 22, 2026

Kaplan Fox & Kilsheimer LLP has announced a class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) on behalf of investors who purchased common stock between February 28, 2024, and February 25, 2026. The lawsuit alleges that PROCEPT falsely claimed consistent handpiece unit sales …

PROCEPT BioRobotics (NASDAQ:PRCT) Trading Down 4.8% - What's Next?

PROCEPT BioRobotics (NASDAQ:PRCT) shares fell 4.8% after reporting mixed Q2 2026 results with revenue growth but a larger-than-expected loss and continued unprofitability. The company faces a class-action lawsuit regarding alleged misleading statements about demand and inventory, adding to investor uncertainty. Despite a CEO stock …

PRCT Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against PROCEPT BioRobotics Corporation and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit

Robbins Geller Rudman & Dowd LLP has filed a class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) on behalf of investors who purchased stock between February 28, 2024, and February 25, 2026. The lawsuit alleges that PROCEPT made materially false and misleading statements …

PROCEPT CLASS ACTION ALERT: Bragar Eagel & Squire, P.C.

Bragar Eagel & Squire, P.C. has filed a class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) on behalf of investors who purchased common stock between February 28, 2024, and February 25, 2026. The lawsuit alleges that Procept misled investors by failing to disclose …

Kaplan Fox Encourages Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to Contact the Firm to Learn About Their Legal Rights

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) on behalf of investors who purchased common stock between February 28, 2024, and February 25, 2026. The lawsuit alleges that PROCEPT artificially inflated its reported U.S. handpiece …

Lost Money on PROCEPT BioRobotics Corporation (PRCT)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm

The Gross Law Firm has issued a notice to shareholders of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to join a class action lawsuit. The suit alleges that PROCEPT BioRobotics Corporation made false or misleading statements regarding an undisclosed discount program that inflated sales and revenue, …

PRCT Investor Announcement: PROCEPT BioRobotics Sued on behalf of Investors to Recover Losses after Artificially Inflated Revenue Leads to 18% Stock Drop

Why PROCEPT BioRobotics (PRCT) Is Up 9.6% After Reaffirming 2026 Revenue Guidance Despite Wider Losses

PROCEPT BioRobotics (PRCT) saw its stock rise 9.6% despite reporting wider net losses in Q2 2026, driven by reaffirming its full-year 2026 revenue guidance of US$390 million to US$410 million. The company's investment narrative centers on Aquablation adoption and the path to sustainable profitability, …

PROCEPT BioRobotics (NASDAQ:PRCT) CEO Larry Wood Purchases 23,900 Shares

PROCEPT BioRobotics CEO Larry Wood purchased 23,900 shares of company stock for approximately $498,315. The company recently reported better-than-expected revenue but a slightly wider loss per share, leading to mixed signals from analysts and a recent downgrade from Wells Fargo. PROCEPT BioRobotics also faces …

Procept BioRobotics CEO Larry Wood buys $498k in stock

PROCEPT BioRobotics CEO Larry Wood recently purchased 23,900 shares of the company's common stock for approximately $498,315, held indirectly through The Larry Wood Trust. This insider buying follows a period of stock momentum and occurs as the company reported a 19% increase in Q2 …

PROCEPT BioRobotics (PRCT) CEO adds 23,900 shares via trust purchase

PROCEPT BioRobotics Corp President and CEO Larry L. Wood, through The Larry Wood Trust, purchased 23,900 shares of common stock on August 7, 2026, at a weighted average price of $20.85 per share. Following this transaction, the trust indirectly holds 23,900 shares, and Wood …

PROCEPT BioRobotics Corporation Investors: September 22, 2026, Deadline in Securities Fraud Class Action Lawsuit - Contact Kessler Topaz Meltzer & Check, LLP

Affected PRCT Investor Summary Who: PROCEPT BioRobotics Corporation (NASDAQ: PRCT)What: Securities fraud class action lawsuit filedClass Period: February 28, 2024 through February 25, 2026Deadline to Seek Lead Plaintiff Status: September 22, 2026Key Lawsuit Allegations: Material misstatements and/or omissions concerning the company’s product demandInvestor Action: …

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages PROCEPT BioRobotics Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – PRCT

NEW YORK, Aug. 09, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February 28, 2024 and February 25, 2026, inclusive (the “Class Period”), of the important …

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages PROCEPT BioRobotics Corporation Investors to ...

The Rosen Law Firm is encouraging investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to join a class action lawsuit. The lawsuit alleges that PROCEPT made materially false and misleading statements about an extensive discount program which artificially inflated reported sales and revenue between February …

PROCEPT BioRobotics Corp. Revenue Breakdown – BMV:PRCT

PROCEPT BioRobotics Corp. (BMV:PRCT) generated 5.55 billion MXN in revenue last year. The "Hand Pieces and Other Consumables" segment was the top performer, contributing 3.27 billion MXN, an increase from 2.53 billion MXN the previous year. The United States was the primary revenue source, …

PROCEPT BioRobotics (PRCT) Stock Sees Fair Value Falls As Analysts Cut Growth Views

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Price targets for PROCEPT BioRobotics have been reset closer to its revised fair value, with many now clustered in the low to mid …

PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock Decline - Investors may Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP

SAN FRANCISCO, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in PROCEPT BioRobotics Corporation (NASDAQ: PRCT) that a securities class action has been filed after repeated surprise unit handpiece sales underperformance and gradual revelations of excess customer inventory levels …

PROCEPT BioRobotics (PRCT) Stock Rises As Revenue Holds Firm And Losses Deepen

PROCEPT BioRobotics (PRCT) stock rose by 5.8% after its Q2 earnings report, despite widening losses. The company reported Q2 sales of US$94.5m and maintained its full-year revenue guidance, indicating sustained growth. However, net losses deepened to US$26.9m, highlighting the company's challenge in balancing revenue …

PROCEPT BioRobotics Corp 1Q 2026: Revenue $94.5M, EPS ($0.47) — 10-Q Summary

PROCEPT BioRobotics Corp (PRCT) reported its first-quarter 2026 results, showing revenue growth to $94.5 million, an increase of 19.3% year-over-year. Despite the revenue rise, the company recorded a net loss of ($26.86M) and a diluted loss per share of ($0.47), both widening compared to …

Kaplan Fox Notifies PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors of a Securities Class Action Deadline on September 22, 2026

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) on behalf of investors who purchased common stock between February 28, 2024, and February 25, 2026. The lawsuit alleges that PROCEPT artificially inflated reported U.S. handpiece unit …

[10-Q] PROCEPT BioRobotics Corp Quarterly Earnings Report

PROCEPT BioRobotics Corp. filed its Form 10-Q quarterly report for the period ending June 30, 2026, disclosing a net loss of $58.5 million on revenues of $177.6 million for the first six months of 2026. The company reported $227.9 million in cash and cash …

PROCEPT BioRobotics reports Q2 2026 revenue $94.5M, net loss $26.9M, reiterates FY26 revenue guide

PROCEPT BioRobotics reported Q2 2026 revenue of $94.5 million and a net loss of $26.9 million, while reiterating its full-year 2026 revenue guidance of $390 million to $410 million. The company achieved a 19% year-over-year revenue increase, with U.S. procedures growing by approximately 21% …

William Blair downgrades PROCEPT BioRobotics (PRCT) to a Hold

PROCEPT gains after Q2 beat; Wells Fargo downgrades

PROCEPT BioRobotics (NASDAQ:PRCT) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS

PROCEPT BioRobotics Corp. filed its Form 10-Q quarterly report for the period ending June 30, 2026, disclosing a net loss of $58.5 million on revenues of $177.6 million for the first six months of 2026. The company reported $227.9 million in cash and cash …

PROCEPT BioRobotics Corporation (PRCT) Reports Q2 Loss, Beats Revenue Estimates

PROCEPT BioRobotics Corporation (PRCT) reported a Q2 loss of $0.47 per share, slightly wider than the Zacks Consensus Estimate of a $0.46 loss, marking an earnings surprise of -2.17%. Despite the loss, the company surpassed revenue expectations, posting $94.5 million against an estimated $92.5 …

Procept Biorobotics earnings in spotlight as growth questions loom

Procept Biorobotics (NASDAQ:PRCT) is set to report second-quarter earnings, with investors focused on procedure growth amidst legal scrutiny and competitive pressures. Analysts anticipate a loss of 46 cents per share on revenue of $92.6 million, representing 17% year-over-year growth. The company faces class-action lawsuits …

PROCEPT delivers 65 robotic systems as U.S. procedures pass 13,100

PROCEPT BioRobotics reported strong Q2 2026 financial results, with revenue up 19% year-over-year to $94.5 million, driven by increased U.S. handpiece, system sales, and international revenue. The company delivered 65 U.S. HYDROS robotic systems and U.S. procedures exceeded 13,100, marking a 21% increase. While …

Earnings Flash (PRCT) PROCEPT BioRobotics Corporation Reports Q2 Revenue $94.5M, vs. FactSet Est of $92.8M